| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851660 | American Heart Journal | 2008 | 7 Pages |
Abstract
This study confirms the limited exposure to the systemic circulation of the eluted drug with the use of the XIENCE V Everolimus-Eluting Coronary Stent System (Abbott Vascular, Santa Clara, CA). Therefore, a systemic cause of adverse events is unlikely.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Marcus MD, Ashok MD, Praveen MD, Jörg MD, Gert MD, Jan J. MD, PhD, Martin MD, Carlos MD, Cornelis J. PhD, Karine PhD, Karolien MSc, MPharm, Patrick W. MD, PhD,